Wegovy users keep weight off for 4 years: How Wegovy helps the heart

  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

News News

United States Latest News,United States Headlines

Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to cover the cost of the effective but expensive drug.

The Danish drugmaker presented the new long-term data on Tuesday at the European Congress on Obesity in Venice, Italy, in a new analysis from a large study for which substantial results had been published last year. “This is the longest study we’ve conducted so far of semaglutide for weight loss,” Martin Holst Lange, Novo’s head of development, said in an interview, referring to the active ingredient in Wegovy and the company’s diabetes drug Ozempic.

Participants were not required to track diet and exercise because it was not an obesity study. Around 17% of trial participants stopped using Wegovy due to side effects, the most common of which was nausea, Novo said in another analysis in the trial published by the drugmaker on Tuesday. Patients in the trial, called Select, lost an average of nearly 10% of their total body weight after 65 weeks on Wegovy.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 707. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study saysThe results shed light on the long-term effects of Wegovy, and could boost Novo Nordisk's case to insurers and governments to cover the costly drug.
Source: CNBC - 🏆 12. / 72 Read more »

Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and WegovyScience and Technology News and Videos
Source: futurism - 🏆 85. / 68 Read more »

Wegovy maker Novo Nordisk down 4%, heads for worst day since OctoberAnalysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source: nbcsandiego - 🏆 524. / 51 Read more »

Wegovy maker Novo Nordisk down 4%, heads for worst day since OctoberAnalysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source: CNBC - 🏆 12. / 72 Read more »

Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortagesNovo Nordisk's Negelle Morris spoke exclusively with ABC News.
Source: ABC - 🏆 471. / 51 Read more »

Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than doubleSales of popular weight loss drug Wegovy more than doubled to 9.38 billion kroner.
Source: CNBC - 🏆 12. / 72 Read more »